Screening for inborn errors of metabolism using untargeted metabolomics and out-of-batch controls
Authors:
- Michiel BongaertsMBMichiel Bongaerts
- Ramon BonteRBRamon Bonte
- Serwet DemirdasSDSerwet Demirdas
- Ed H. JacobsEJEd H. Jacobs
- E. OussorenEOE. Oussoren
- Ans T. van der PloegAPAns T. van der Ploeg
- Margreet A.E.M. WagenmakersMWMargreet A.E.M. Wagenmakers
- Robert M.W. HofstraRHRobert M.W. Hofstra
- Henk J. BlomHBHenk J. Blom
- Marcel J.T. ReindersMRMarcel J.T. Reinders
- George J. G. RuijterGRGeorge J. G. Ruijter
Preprint
Abstract
Motivation: Untargeted metabolomics is an emerging technology in the laboratory diagnosis of inborn errors of metabolism (IEM). In order to judge if metabolite levels are abnormal, analysis of a large number of reference samples is crucial to correct for variations in metabolite concentrations resulting from factors such as diet, age and gender. However, a large number of controls requires the use of out-of-batch controls, which is hampered by the semi-quantitative nature of untargeted metabolomics data, i.e. technical variations between batches. Methods to merge and accurately normalize data from multiple batches are urgently needed. Methods & results: Based on six metrics, we compared existing normalization methods on their ability to reduce batch effects from eight independently processed batches. Many of those showed marginal performances, which motivated us to develop Metchalizer , a normalization method which uses 17 stable isotope-labeled internal standards and a mixed effect model. In addition, we propose a regression model with age- and sex as covariates fitted on control samples obtained from all eight batches. Metchalizer applied on log-transformed data showed the most promising performance on batch effect removal as well as in the detection of 178 known biomarkers across 45 IEM patient samples and performed at least similar to an approach using 15 within-batch controls. Furthermore, our regression model indicates that 10-24% of the considered features showed significant age-dependent variations. Conclusions: Our comprehensive comparison of normalization methods showed that our Log-Metchalizer approach enables the use out-of-batch controls to establish clinically-relevant reference values for metabolite concentrations. These findings opens possibilities to use large scale out-of-batch control samples in a clinical setting, increasing throughput and detection accuracy. Availability: Metchalizer is available at https://github.com/mbongaerts/Metchalizer/Keywords
All Related Versions
- Published version: Metabolites, 11 (1), 8.
This publication has 19 references indexed in Scilit:
- Untargeted Metabolomics-Based Screening Method for Inborn Errors of Metabolism using Semi-Automatic Sample Preparation with an UHPLC- Orbitrap-MS PlatformMetabolites, 2019
- Untargeted metabolomics identifies unique though benign biochemical changes in patients with pathogenic variants in UROC1Molecular Genetics and Metabolism Reports, 2019
- Direct Infusion Based Metabolomics Identifies Metabolic Disease in Patients’ Dried Blood Spots and PlasmaMetabolites, 2019
- Next‐generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patientsJournal of Inherited Metabolic Disease, 2018
- Fast and accurate quantitative organic acid analysis with LC‐QTOF/MS facilitates screening of patients for inborn errors of metabolismJournal of Inherited Metabolic Disease, 2018
- Individual variability in human blood metabolites identifies age-related differencesProceedings of the National Academy of Sciences, 2016
- What can go wrong at the data normalization step for identification of biomarkers?Journal of Chromatography A, 2014
- Analysis of the Adult Human Plasma MetabolomePharmacogenomics, 2008
- Faster cyclic loess: normalizing RNA arrays via linear modelsBioinformatics, 2004
- Variance stabilization applied to microarray data calibration and to the quantification of differential expressionBioinformatics, 2002